Delivery Order SPE2D020D0014-SPE2D323F151S

Award Date 8/18/23
Potential Completion Date 8/23/23
Potential Value $21
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $10,500 delivery order to Pfizer Inc. for the supply of ondansetron hydrochloride injection. The firm fixed price order is for 4561651751 units of the 4 mg/2 ml antiemetic drug to be delivered from Pfizer's New York City location between July 31 and August 3, 2023. As a major provider of pharmaceuticals to the Department of Defense through indefinite delivery/indefinite quantity contracts managed by DLA Troop Support, Pfizer will...
The Defense Logistics Agency Troop Support Medical awarded a $10,500 delivery order to Pfizer Inc. for the supply of 4561725610 Ondansetron HCl (PF) 4 mg/2 ml injections. As the prime contractor, Pfizer will deliver the pharmaceutical products from its New York location to the agency by August 10, 2023 to fulfill requirements under an existing contract vehicle. No set aside designation or subcontracting arrangements were indicated. This delivery order provides needed medical supplies to...
<p>The Defense Logistics Agency Troop Support Medical awarded Pfizer Inc. a $21 firm fixed price delivery order contract to supply ondansetron HCL (PF) 4 mg/2 ml injections. The contract has a performance period through August 25, 2023 for place of performance in New York, NY. The agency utilizes such contracts to support its medical supply needs. No set aside provision was designated for this award made to the large pharmaceutical manufacturer.</p>
<p>This delivery order for $21 of ondansetron hydrochloride (PF) 4 mg/2 ml injections was awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. on August 22, 2023, with a completion date of August 25, 2023. The firm fixed price contract was issued under an existing vehicle to supply the agency's medical programs with the requested pharmaceutical products. No set-aside designation was applied to this award. Place of performance will be Pfizer's New York City location.</p>
The Defense Logistics Agency Troop Support Medical awarded a $10,500 delivery order to Pfizer Inc. for the supply of ondansetron hydrochloride injection. The firm fixed price order is for the delivery of the pharmaceutical product to a location in New York. Performance will take place between June 28 and July 3, 2023. DLA Troop Support Medical utilizes contracts such as this to provide medical supplies and equipment to all branches of the United States armed forces worldwide. No subcontractors...
The Defense Logistics Agency Troop Support Medical awarded a $10,500 delivery order to Pfizer Inc. for the supply of ondansetron hydrochloride injection. The firm fixed price order is for the delivery of the pharmaceutical product to a location in New York. Performance will take place between July 10-13, 2023. DLA Troop Support Medical utilizes contracts to provide medical supplies and equipment to all branches of the United States armed forces. No subcontractors or set aside designations were...
The Defense Logistics Agency Troop Support Medical awarded a $55,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ondansetron hydrochloride injection, USP 4 mg/2 mL vials. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 25, 2023 through August 28, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and...
The Defense Logistics Agency awarded a $273.31 delivery order contract to Amerisourcebergen Drug Corporation for ondansetron hydrochloride injection. The firm fixed price contract calls for the prime contractor to provide 4 mg/2 ml vials of the drug to support Defense Logistics Agency programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 25 to July 26, 2023. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency Troop Support Medical awarded a $36,960 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 mg/2 ml vials of ondansetron hydrochloride. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023 to supply the antiemetic medication. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at fifty-nine thousand seven hundred dollars to Amerisourcebergen Drug Corporation for ondansetron hydrochloride injection. The contract calls for the delivery of ondansetron hydrochloride 4 mg/2 ml vials to a location in Conshohocken, Pennsylvania by August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for...
  • SPE2D020D0014
    Indefinite Delivery Contract
  • SPE2D020D0014-SPE2D323F151S
    Delivery Order

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $21,000 to Pfizer Inc., doing business as Pfizer, for the delivery of ondansetron hydrochloride injection. The contract has a period of performance from August 18-23, 2023, with all work to be conducted at Pfizer's place of performance in New York, New York. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity vehicle to supply pharmaceutical products in support of the Department of Defense's medical readiness and contingency operations programs. No subcontractors or set aside designations were identified.

Generated 12/24/23, 4:08 PM